This topic contains a solution. Click here to go to the answer

Author Question: Secondary prevention in the occupational health arena might include: 1. Providing education on ... (Read 97 times)

kshipps

  • Hero Member
  • *****
  • Posts: 571
Secondary prevention in the occupational health arena might include:
 
  1. Providing education on safety in the workplace to prevent injury
  2. Working with chronically diabetic workers to ensure appropriate medications
  3. Screening for hearing loss resulting from noise levels in the plants
  4. Ensuring that a person with cardiovascular disease attends a rehab program

Question 2

In the epidemiologic triad, an example of a host factor would be
 
  1. Crowding
  2. Shift work
  3. Worker's family
  4. Chemical exposure



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kusterl

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

ANS: 3

Answer to Question 2

ANS: 3




kshipps

  • Member
  • Posts: 571
Reply 2 on: Jul 8, 2018
Excellent


Viet Thy

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library